Powering precision medicine for the brain
Beacon’s EEG neurobiomarker platform is engineered to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric disease.
What We Do
EfficacyQuantitative assessment of treatment impact on EEG and ERP data ensure clinical endpoints are reached
Safety MonitoringEEG reports delivered with unprecedented speed and accuracy, eliminating adjudication with enhanced inclusion/exclusion criteria
Population StratificationIdentify optimal patient populations to maximize effective treatments
Enabled by our end-to-end augmented EEG platform
State of the Art Machine Learning
World-Class Clinical EEG Database
Expert Neurologist Network
How We Create Impact
Translational ResearchAnalyze existing EEG for insights into mechanism, PK/PD and patient stratification to guide further development efforts
Clinical Trial OptimizationImproved cohort selection and proactive in-trial monitoring can mitigate risk of trial failure due to severe side effects or missed endpoints
Commercial DifferentiationBest-in-class safety profiles and at-home monitoring are highly valued by both patients and clinicians
Trusted Partners & Investors
Partnerships
We partner with biopharma companies, academic medical centers, and neurotechnology developers to improve the diagnosis and treatment of neurological and psychiatric diseases.